View Section: Cash Flow Statement
RE
Regeneron Pharmaceuticals IncNASDAQ REGN Stock Report
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
124.33
Mega
Exchange
XNAS - Nasdaq
RE
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
124.33
Exchange
XNAS - Nasdaq
RE
Ex-dividend date
Amount
Share price
Yield
This ticker has no dividend history